To assess outcomes of thrombolysis for intermediate-risk PE by meta-analysis
8 CRTs involving 1,755 patients were included.
Thrombolysis leads to lower mortality than anticoagulation.
Thrombolysis leads to lower recurrent PE than anticoagulation.
Thrombolysis leads to higher major and minor bleeding risks than anticoagulation.